Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the website listed below. If a full
report of the study results is available, it also can be found there.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02669667”
into the search box and click “Search”.
The full title of your study is: A Phase 1a Randomized, Blinded,
Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and
Tolerability of MEDI9314 in Healthy Adult Subjects
The protocol number of your study is: D4361C00002
MedImmune, LLC, a member of the AstraZeneca Group, sponsored this study and
has its headquarters at 1800 Concord Pike, Wilmington, DE 19850.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and
find medical treatments for participants.
The Center for Information & Study on Clinical Research Synchrogenix is a worldwide medical and regulatory
Participation (CISCRP) is a non-profit organization writing organization and is not involved in recruiting
focused on educating and informing the public about patients or in conducting clinical studies.
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP Synchrogenix Headquarters
One Liberty Square, Suite 510 2 Righter Parkway, Suite 205
Boston, MA 02109 Wilmington, DE 19803
1-877-MED-HERO 1-302-892-4800
www.ciscrp.org www.synchrogenix.com
Version: V2.0 05/2018 4